| 摘要 |
The invention pertains to novel phospholipid derivatives of nucleosides of the general formula (I), wherein R1 is an optionally mono- or polysubstituted, straight-chain or branched, saturated or unsaturated aliphatic radical with 914 carbon atoms; R2 is an optionally mono- or polysubstituted, straight-chain or branched, saturated or unsaturated aliphatic radical with 8-12 carbon atoms; m is equal to 2 or 3; A is a methylene group or oxygen, and Nuc can be a nucleoside or a radical derived from a nucleoside derivative, and to their tautomers and their physiologically tolerable salts of inorganic and organic acids or bases. The invention also pertains to drugs containing these compounds.
|
